Home
/
Treatment
/
KIT and PDGFR inhibitor

KIT and PDGFR inhibitor

August 11, 2017

	KIT and PDGFR inhibitor
Trade Name
Orphan Indication	Glioblastoma
USA Market Approval	USA
USA Designation Date	2017-08-07 00:00:00
Sponsor	Deciphera Pharmaceuticals, LLC;500 Totten Pond Road;Waltham, Massachusetts, 02451

Related Access Program

Center Trials & Treatment – Glioblastoma by Gene Expression Profile Center Trials & Treatment – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Celldex Therapeutics – Recurrent GBM